Applied dna announces third quarter fiscal year 2024 financial results

- conference call/webcast scheduled for today at 4:30 pm et - stony brook, ny / accesswire / august 8, 2024 / applied dna sciences, inc. (nasdaq:apdn) ("applied dna" or the "company"), a leader in pcr-based dna technologies, today announced consolidated financial results for its third fiscal quarter ended june 30, 2024. the company's form 10-q can be viewed at https://investors.adnas.com/sec-filings/.
APDN Ratings Summary
APDN Quant Ranking